01.06.2013 Views

4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta

4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta

4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical Cytology - Plenary and Invited Lectures<br />

JUVENILE MYELOMONOCYTIC LEUKEMIA WITH PTPN11 MUTATION IN A<br />

23-MONTH-OLD GIRL<br />

Jakovljević G1 , Kardum-Skelin I2 , Nakić M1 , Batinić D3 , Rogošić S1 1 Department of Hematology and Oncology, Pediatric Clinic, Children’s Hospital Zagreb,<br />

Zagreb, Croatia<br />

2 Laboratory for Cytology and Hematology, Clinic of Internal Medicine, Merkur<br />

University Hospital, Zagreb, Croatia<br />

3 University Hospital Center Zagreb, Department of Laboratory Diagnosis, Zagreb,<br />

Croatia<br />

Juvenile myelomonocytic leukemia (JMML) is a rare clonal myeloproliferative disorder,<br />

afflicting young children, with 2 years median age at diagnosis. The natural course of<br />

JMML is rapidly fatal with 80% of patients surviving less than 3 years. Allogeneic hematopoietic<br />

stem cell transplantation (HSCT) is the only curative treatment modality<br />

for JMML, with event-free survival in about half of the children. We present a case of<br />

23-month-old girl with JMML and a somatic PTPN11 mutation. She was hospitalized<br />

due to upper respiratory tract infection, fever, rash and diarrhea. Enlarged liver, spleen,<br />

mesenterial and retroperitoneal lymph nodes were observed at presentation as well as<br />

severe elevation of white blood cell (WBC) count with monocytosis and myeloid progenitors<br />

present in peripheral blood. Hemoglobin F was also elevated. Subsequently, her<br />

bone marrow aspiration showed morphology suggestive of JMML, an unspecific immune<br />

phenotype and normal karyotype. Mutation analysis revealed a mutation in the PTPN11<br />

gene. The girl was diagnosed with JMML and treated with purinethol and low doses<br />

of cytarabine which resulted in normalization of WBC count and decrease in liver and<br />

spleen size. Her sister was a suitable bone marrow donor and allogeneic HSCT was<br />

successfully performed. Five months later she is in a good condition and in a complete<br />

remission of JMML. Early diagnosis and allogeneic HSCT were crucial for successful<br />

treatment outcome.<br />

gordanajakovljevic@yahoo.com<br />

45<br />

4 th <strong>Croatian</strong> <strong>Congress</strong> of Clinical Cytology / 1 st <strong>Croatian</strong> Symposium of Analytical Cytology / 2 nd <strong>Croatian</strong> Symposium of Cytotechnology

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!